Brian Kobilka is currently a professor in the department of Molecular and Cellular Physiology at Stanford University School of Medicine.
| FactSnippet No. 1,067,197 |
Brian Kobilka is currently a professor in the department of Molecular and Cellular Physiology at Stanford University School of Medicine.
| FactSnippet No. 1,067,197 |
Brian Kobilka is a co-founder of ConfometRx, a biotechnology company focusing on G protein-coupled receptors.
| FactSnippet No. 1,067,198 |
Brian Kobilka was named a member of the National Academy of Sciences in 2011.
| FactSnippet No. 1,067,199 |
Brian Kobilka attended St Mary's Grade School in Little Falls, Minnesota, a part of the Roman Catholic Diocese of Saint Cloud.
| FactSnippet No. 1,067,200 |
Brian Kobilka worked in research as a postdoctoral fellow under Robert Lefkowitz at Duke University, where he started work on cloning the ß2-adrenergic receptor.
| FactSnippet No. 1,067,201 |
Brian Kobilka was a Howard Hughes Medical Institute investigator from 1987 to 2003.
| FactSnippet No. 1,067,202 |
Brian Kobilka is best known for his research on the structure and activity of G protein-coupled receptors ; in particular, work from Brian Kobilka's laboratory determined the molecular structure of the ß2-adrenergic receptor.
| FactSnippet No. 1,067,203 |
Brian Kobilka received the 2012 Nobel Prize in Chemistry with Robert Lefkowitz for his work on G protein-coupled receptors.
| FactSnippet No. 1,067,204 |
In 2017, Brian Kobilka received the Golden Plate Award of the American Academy of Achievement.
| FactSnippet No. 1,067,205 |